13 In addition, triple negative breast cancer (TNBC) characterized by low expression of estrogen, progesterone and Her2 receptors, is associated with overexpression of EGFR.14 In addition to the role of EGFR in breast cancer progression, aromatase enzyme is critical for breast cancer development and progression. This evidence concerns the gene CYP19A1 and breast carcinoma.